![Life | Free Full-Text | Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies Life | Free Full-Text | Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies](https://pub.mdpi-res.com/life/life-11-00174/article_deploy/html/images/life-11-00174-ag-550.jpg?1614233052)
Life | Free Full-Text | Single Nucleotide Polymorphism in the IL17A Gene Is Associated with Interstitial Lung Disease Positive to Anti-Jo1 Antisynthetase Autoantibodies
![Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies | BMC Pulmonary Medicine | Full Text Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies | BMC Pulmonary Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-021-01737-7/MediaObjects/12890_2021_1737_Fig1_HTML.png)
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies | BMC Pulmonary Medicine | Full Text
![Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-36395-z/MediaObjects/41598_2018_36395_Fig1_HTML.png)
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies | Scientific Reports
![Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80% More in overlap Low in IBM Defined antibodies:50% - ppt download Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80% More in overlap Low in IBM Defined antibodies:50% - ppt download](https://images.slideplayer.com/15/4723201/slides/slide_3.jpg)
Autoantibodies in PM and DM Autoantibodies:>90% Autoantibodies:>90% Positive ANA:60-80% Positive ANA:60-80% More in overlap Low in IBM Defined antibodies:50% - ppt download
![Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | Semantic Scholar Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/02b83683ec2de12b09bfd44e7decc5fb71c8dfa3/3-Figure1-1.png)
Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response | Semantic Scholar
![Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies](https://static.hindawi.com/articles/jir/volume-2023/2988422/figures/2988422.fig.003.jpg)
Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies
![SocvenezolanaReumato on X: "El anti-Jo-1 es el Ac anti- sintetasa mas comun y se correlaciona #miositis, enfermedad pulmonar #artritis y mano de mecanico #reumatologia https://t.co/UXlT1v9DUw" / X SocvenezolanaReumato on X: "El anti-Jo-1 es el Ac anti- sintetasa mas comun y se correlaciona #miositis, enfermedad pulmonar #artritis y mano de mecanico #reumatologia https://t.co/UXlT1v9DUw" / X](https://pbs.twimg.com/media/C-SbfRPXsAAY6oS.jpg)
SocvenezolanaReumato on X: "El anti-Jo-1 es el Ac anti- sintetasa mas comun y se correlaciona #miositis, enfermedad pulmonar #artritis y mano de mecanico #reumatologia https://t.co/UXlT1v9DUw" / X
![StudyXing Medicine on X: "Polymyositis: Autoimmune, inflammatory muscle destruction --> proximal bilateral wkness (shoulders, hips MC), fatigue, inability to rise from sitting; Pos+ anti-Jo-1, anti-SRP, anti-Mi-2 antibodies, high CK; Bx: endomysial ... StudyXing Medicine on X: "Polymyositis: Autoimmune, inflammatory muscle destruction --> proximal bilateral wkness (shoulders, hips MC), fatigue, inability to rise from sitting; Pos+ anti-Jo-1, anti-SRP, anti-Mi-2 antibodies, high CK; Bx: endomysial ...](https://pbs.twimg.com/media/FTOpXDkXwAA_dKG.jpg:large)
StudyXing Medicine on X: "Polymyositis: Autoimmune, inflammatory muscle destruction --> proximal bilateral wkness (shoulders, hips MC), fatigue, inability to rise from sitting; Pos+ anti-Jo-1, anti-SRP, anti-Mi-2 antibodies, high CK; Bx: endomysial ...
![Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2019/08/GTUOHVCE-699756-1-ANY.png)
Identifying Jo-1-Specific B Cells in the Primary Immune Repertoire in Idiopathic Inflammatory Myopathies - ACR Meeting Abstracts
![Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies](https://static.hindawi.com/articles/jir/volume-2023/2988422/figures/2988422.fig.002.jpg)